SAB Biotherapeutics (SABS) Revenue (2021 - 2026)
SAB Biotherapeutics (SABS) revenue from Mar 31, 2021 to Mar 31, 2026. The TTM SAB Biotherapeutics (SABS) revenue is $0. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Annual Revenue change of SAB Biotherapeutics (SABS)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $0 | N/A |
| 2025 | $0 | -100.00% |
| 2024 | $1.32M | -41.07% |
| 2023 | $2.24M | -90.63% |
| 2022 | $24M | -60.74% |
| 2021 | $61M | +10.21% |
| 2020 | $55M | N/A |